過活動膀胱治療の世界市場 2020年

• 英文タイトル：Global Overactive Bladder Treatment Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114752 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、過活動膀胱治療の世界市場を調査対象にし、過活動膀胱治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（薬物、デバイス）、用途別分析（特発性過活動膀胱、神経性過活動膀胱）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Allergan、Johnson & Johnson、Astellas Pharma、Pfizer、KYORIN Pharmaceutical、Medtronic ・企業別売上、市場シェア ・過活動膀胱治療の地域別市場分析 ・過活動膀胱治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・過活動膀胱治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・過活動膀胱治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・過活動膀胱治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・過活動膀胱治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・過活動膀胱治療の種類別市場規模2015-2020：薬物、デバイス ・過活動膀胱治療の用途別市場規模2015-2020：特発性過活動膀胱、神経性過活動膀胱 ・過活動膀胱治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The Overactive Bladder Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Overactive Bladder Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.9%% in the forecast period of 2020 to 2025 and will expected to reach USD 6065.1 million by 2025, from USD 5415.8 million in 2019.

Market segmentation
Overactive Bladder Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Overactive Bladder Treatment market has been segmented into:
Drugs
Device

By Application, Overactive Bladder Treatment has been segmented into:
Idiopathic Overactive Bladder
Neurogenic Overactive Bladder

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Overactive Bladder Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Overactive Bladder Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Overactive Bladder Treatment market.

The report offers in-depth assessment of the growth and other aspects of the Overactive Bladder Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Overactive Bladder Treatment Market Share Analysis
Overactive Bladder Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Overactive Bladder Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Overactive Bladder Treatment sales, revenue and market share for each player covered in this report.

The major players covered in Overactive Bladder Treatment are:
Allergan
Johnson & Johnson
Astellas Pharma
Pfizer
KYORIN Pharmaceutical
Medtronic
Among other players domestic and global, Overactive Bladder Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

---

1 Overactive Bladder Treatment Market Overview
1.1 Product Overview and Scope of Overactive Bladder Treatment
1.2 Classification of Overactive Bladder Treatment by Type
1.2.1 Global Overactive Bladder Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Overactive Bladder Treatment Revenue Market Share by Type in 2019
1.2.3 Drugs
1.2.4 Device
1.3 Global Overactive Bladder Treatment Market by Application
1.3.1 Overview: Global Overactive Bladder Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Idiopathic Overactive Bladder
1.3.3 Neurogenic Overactive Bladder
1.4 Global Overactive Bladder Treatment Market by Regions
1.4.1 Global Overactive Bladder Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Overactive Bladder Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Overactive Bladder Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Overactive Bladder Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Overactive Bladder Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Overactive Bladder Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Overactive Bladder Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan
2.1.1 Allergan Details
2.1.2 Allergan Major Business
2.1.3 Allergan SWOT Analysis
2.1.4 Allergan Product and Services
2.1.5 Allergan Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson SWOT Analysis
2.2.4 Johnson & Johnson Product and Services
2.2.5 Johnson & Johnson Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astellas Pharma
2.3.1 Astellas Pharma Details
2.3.2 Astellas Pharma Major Business
2.3.3 Astellas Pharma SWOT Analysis
2.3.4 Astellas Pharma Product and Services
2.3.5 Astellas Pharma Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 KYORIN Pharmaceutical
2.5.1 KYORIN Pharmaceutical Details
2.5.2 KYORIN Pharmaceutical Major Business
2.5.3 KYORIN Pharmaceutical SWOT Analysis
2.5.4 KYORIN Pharmaceutical Product and Services
2.5.5 KYORIN Pharmaceutical Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Medtronic
2.6.1 Medtronic Details
2.6.2 Medtronic Major Business
2.6.3 Medtronic Product and Services
2.6.4 Medtronic Overactive Bladder Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Overactive Bladder Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Overactive Bladder Treatment Players Market Share
3.2.2 Top 10 Overactive Bladder Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Overactive Bladder Treatment Revenue and Market Share by Regions
4.2 North America Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
5 North America Overactive Bladder Treatment Revenue by Countries
5.1 North America Overactive Bladder Treatment Revenue by Countries (2015-2020)
5.2 USA Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
6 Europe Overactive Bladder Treatment Revenue by Countries
6.1 Europe Overactive Bladder Treatment Revenue by Countries (2015-2020)
6.2 Germany Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
6.4 France Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Overactive Bladder Treatment Revenue by Countries
7.1 Asia-Pacific Overactive Bladder Treatment Revenue by Countries (2015-2020)
7.2 China Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
7.5 India Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
8 South America Overactive Bladder Treatment Revenue by Countries
8.1 South America Overactive Bladder Treatment Revenue by Countries (2015-2020)
8.2 Brazil Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Overactive Bladder Treatment by Countries
9.1 Middle East & Africa Overactive Bladder Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Overactive Bladder Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Overactive Bladder Treatment Market Forecast by Type (2019-2024)
10.3 Drugs Revenue Growth Rate (2015-2025)
10.4 Device Revenue Growth Rate (2015-2025)
11 Global Overactive Bladder Treatment Market Segment by Application
11.1 Global Overactive Bladder Treatment Revenue Market Share by Application (2015-2020)
11.2 Overactive Bladder Treatment Market Forecast by Application (2019-2024)
11.3 Idiopathic Overactive Bladder Revenue Growth (2015-2020)
11.4 Neurogenic Overactive Bladder Revenue Growth (2015-2020)
12 Global Overactive Bladder Treatment Market Size Forecast (2021-2025)
12.1 Global Overactive Bladder Treatment Market Size Forecast (2021-2025)
12.2 Global Overactive Bladder Treatment Market Forecast by Regions (2021-2025)
12.3 North America Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
12.6 South America Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Overactive Bladder Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Overactive Bladder Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Overactive Bladder Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Overactive Bladder Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Overactive Bladder Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Allergan Corporate Information, Location and Competitors
Table 7. Allergan Overactive Bladder Treatment Major Business
Table 8. Allergan Overactive Bladder Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Allergan SWOT Analysis
Table 10. Allergan Overactive Bladder Treatment Product and Solutions
Table 11. Allergan Overactive Bladder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Johnson & Johnson Corporate Information, Location and Competitors
Table 13. Johnson & Johnson Overactive Bladder Treatment Major Business
Table 14. Johnson & Johnson Overactive Bladder Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Johnson & Johnson SWOT Analysis
Table 16. Johnson & Johnson Overactive Bladder Treatment Product and Solutions
Table 17. Johnson & Johnson Overactive Bladder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Astellas Pharma Corporate Information, Location and Competitors
Table 19. Astellas Pharma Overactive Bladder Treatment Major Business
Table 20. Astellas Pharma Overactive Bladder Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Astellas Pharma SWOT Analysis
Table 22. Astellas Pharma Overactive Bladder Treatment Product and Solutions
Table 23. Astellas Pharma Overactive Bladder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Pfizer Corporate Information, Location and Competitors
Table 25. Pfizer Overactive Bladder Treatment Major Business
Table 26. Pfizer Overactive Bladder Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Pfizer SWOT Analysis
Table 28. Pfizer Overactive Bladder Treatment Product and Solutions
Table 29. Pfizer Overactive Bladder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. KYORIN Pharmaceutical Corporate Information, Location and Competitors
Table 31. KYORIN Pharmaceutical Overactive Bladder Treatment Major Business
Table 32. KYORIN Pharmaceutical Overactive Bladder Treatment Total Revenue (USD Million) (2017-2018)
Table 33. KYORIN Pharmaceutical SWOT Analysis
Table 34. KYORIN Pharmaceutical Overactive Bladder Treatment Product and Solutions
Table 35. KYORIN Pharmaceutical Overactive Bladder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Medtronic Corporate Information, Location and Competitors
Table 37. Medtronic Overactive Bladder Treatment Major Business
Table 38. Medtronic Overactive Bladder Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Medtronic SWOT Analysis
Table 40. Medtronic Overactive Bladder Treatment Product and Solutions
Table 41. Medtronic Overactive Bladder Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global Overactive Bladder Treatment Revenue (Million USD) by Players (2015-2020)
Table 43. Global Overactive Bladder Treatment Revenue Share by Players (2015-2020)
Table 44. Global Overactive Bladder Treatment Revenue (Million USD) by Regions (2015-2020)
Table 45. Global Overactive Bladder Treatment Revenue Market Share by Regions (2015-2020)
Table 46. North America Overactive Bladder Treatment Revenue by Countries (2015-2020)
Table 47. North America Overactive Bladder Treatment Revenue Market Share by Countries (2015-2020)
Table 48. Europe Overactive Bladder Treatment Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific Overactive Bladder Treatment Revenue (Million USD) by Countries (2015-2020)
Table 50. South America Overactive Bladder Treatment Revenue by Countries (2015-2020)
Table 51. South America Overactive Bladder Treatment Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa Overactive Bladder Treatment Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa Overactive Bladder Treatment Revenue Market Share by Countries (2015-2020)
Table 54. Global Overactive Bladder Treatment Revenue (Million USD) by Type (2015-2020)
Table 55. Global Overactive Bladder Treatment Revenue Share by Type (2015-2020)
Table 56. Global Overactive Bladder Treatment Revenue Forecast by Type (2021-2025)
Table 57. Global Overactive Bladder Treatment Revenue by Application (2015-2020)
Table 58. Global Overactive Bladder Treatment Revenue Share by Application (2015-2020)
Table 59. Global Overactive Bladder Treatment Revenue Forecast by Application (2021-2025)
Table 60. Global Overactive Bladder Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Overactive Bladder Treatment Picture
Figure 2. Global Overactive Bladder Treatment Revenue Market Share by Type in 2019
Figure 3. Drugs Picture
Figure 4. Device Picture
Figure 5. Overactive Bladder Treatment Revenue Market Share by Application in 2019
Figure 6. Idiopathic Overactive Bladder Picture
Figure 7. Neurogenic Overactive Bladder Picture
Figure 8. Global Overactive Bladder Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Overactive Bladder Treatment Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Overactive Bladder Treatment Revenue Market Share in 2019
Figure 17. Global Top 10 Players Overactive Bladder Treatment Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Overactive Bladder Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Overactive Bladder Treatment Revenue Market Share by Regions (2015-2020)
Figure 21. Global Overactive Bladder Treatment Revenue Market Share by Regions in 2018
Figure 22. North America Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 23. Europe Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 25. South America Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 27. North America Overactive Bladder Treatment Revenue Market Share by Countries (2015-2020)
Figure 28. North America Overactive Bladder Treatment Revenue Market Share by Countries in 2019
Figure 29. USA Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Canada Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Europe Overactive Bladder Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Overactive Bladder Treatment Revenue Market Share by Countries in 2019
Figure 34. Germany Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 35. UK Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 36. France Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Russia Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Italy Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Overactive Bladder Treatment Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Overactive Bladder Treatment Revenue Market Share by Countries in 2019
Figure 41. China Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Japan Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Korea Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 44. India Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 46. South America Overactive Bladder Treatment Revenue Market Share by Countries (2015-2020)
Figure 47. South America Overactive Bladder Treatment Revenue Market Share by Countries in 2019
Figure 48. Brazil Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Overactive Bladder Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Overactive Bladder Treatment Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 53. UAE Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Overactive Bladder Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Global Overactive Bladder Treatment Revenue Share by Type (2015-2020)
Figure 57. Global Overactive Bladder Treatment Revenue Share by Type in 2019
Figure 58. Global Overactive Bladder Treatment Market Share Forecast by Type (2021-2025)
Figure 59. Global Drugs Revenue Growth Rate (2015-2020)
Figure 60. Global Device Revenue Growth Rate (2015-2020)
Figure 61. Global Overactive Bladder Treatment Revenue Share by Application (2015-2020)
Figure 62. Global Overactive Bladder Treatment Revenue Share by Application in 2019
Figure 63. Global Overactive Bladder Treatment Market Share Forecast by Application (2021-2025)
Figure 64. Global Idiopathic Overactive Bladder Revenue Growth Rate (2015-2020)
Figure 65. Global Neurogenic Overactive Bladder Revenue Growth Rate (2015-2020)
Figure 66. Global Overactive Bladder Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Overactive Bladder Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Overactive Bladder Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
Figure 70. Europe Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
Figure 72. South America Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Overactive Bladder Treatment Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---